In the Netherlands, clinical isolation of nontuberculous mycobacteria (NTM) has increased over the past decade. Proper identification of isolates is important, as NTM species differ strongly in clinical relevance. Most of the currently applied identification methods cannot distinguish between all different Mycobacterium species and complexes within species. rpoB gene sequencing exhibits a promising level of discrimination among rapidly and slowly growing mycobacteria, including the Mycobacterium avium complex. In this study, we prospectively compared rpoB gene sequencing with our routine algorithm of reverse line blot identification combined with partial 16S rRNA gene sequencing of 455 NTM isolates. rpoB gene sequencing identified 403 isolates to species level as 45 different known species and identified 44 isolates to complex level, and eight isolates remained unidentifiable to species level. In contrast, our reference reverse line blot assay with adjunctive 16S rRNA gene sequencing identified 390 isolates to species level (30 distinct species) and identified 56 isolates to complex level, and nine isolates remained unidentified. The higher discriminatory power of rpoB gene sequencing results largely from the distinction of separate species within complexes and subspecies. Also, Mycobacterium gordonae, Mycobacterium kansasii, and Mycobacterium interjectum were separated into multiple groupings with relatively low sequence similarity (98 to 94%), suggesting that these are complexes of closely related species. We conclude that rpoB gene sequencing is a more discriminative identification technique than the combination of reverse line blot and 16S rRNA gene sequencing and could introduce a major improvement in clinical care of NTM disease and the research on the epidemiology and clinical relevance of NTM. N ontuberculous mycobacteria (NTM) are environmental bacteria that incidentally cause opportunistic infections in humans. In the Netherlands, an aging population and increasing prevalence of chronic disorders like chronic obstructive pulmonary disease (COPD) have led to an increase in clinical NTM isolation, mainly from pulmonary specimens (1). To determine the clinical relevance of NTM, the Statement by the American Thoracic Society and the Infectious Disease Society of America offers an important support to guide clinicians (2). At present, more than 160 distinct Mycobacterium species have been validly published (http://www.bacterio.net/mycobacterium.html). The clinical relevance of isolated NTM differs strongly by species, with a spectrum ranging from species which should nearly always be considered pathogenic (e.g., Mycobacterium kansasii and Mycobacterium malmoense) to typical saprophytes, like Mycobacterium gordonae and Mycobacterium phlei (3). Optimal treatment regimens also differ by species, with major differences between slowly and rapidly growing NTM (4). Because of these differences in clinical relevance and specific treatment regimens, accurate species identification of isolated NTM is of the utmost importance.
N
ontuberculous mycobacteria (NTM) are environmental bacteria that incidentally cause opportunistic infections in humans. In the Netherlands, an aging population and increasing prevalence of chronic disorders like chronic obstructive pulmonary disease (COPD) have led to an increase in clinical NTM isolation, mainly from pulmonary specimens (1) . To determine the clinical relevance of NTM, the Statement by the American Thoracic Society and the Infectious Disease Society of America offers an important support to guide clinicians (2) . At present, more than 160 distinct Mycobacterium species have been validly published (http://www.bacterio.net/mycobacterium.html). The clinical relevance of isolated NTM differs strongly by species, with a spectrum ranging from species which should nearly always be considered pathogenic (e.g., Mycobacterium kansasii and Mycobacterium malmoense) to typical saprophytes, like Mycobacterium gordonae and Mycobacterium phlei (3) . Optimal treatment regimens also differ by species, with major differences between slowly and rapidly growing NTM (4) . Because of these differences in clinical relevance and specific treatment regimens, accurate species identification of isolated NTM is of the utmost importance.
Since the early 1990s, sequence analysis of the 16S rRNA gene has served as the gold standard in identification of mycobacteria (5) . After the introduction of commercial line probe assays and other molecular probe assays, most laboratories implemented these assays as a rapid first identification to overcome the practical or financial inaccessibility of DNA sequencers and to reduce turnaround time. Although 16S rRNA gene sequencing offers much more resolution in identification of NTM than line blot assays, it still lacks discrimination for some groups of NTM, especially among the rapid growers in the Mycobacterium fortuitum and Mycobacterium chelonae-abscessus complexes (6, 7) . Therefore, DNA sequence analysis of the rpoB gene was suggested in previous studies as a more suitable tool for identification of NTM than 16S rRNA genes (8) , and promising results have been obtained both among rapidly growing mycobacteria (RGM) (9) and within the M. avium complex (8) . It has also been observed that the rpoB sequence-based phylogenetic tree was similar to a concatenated tree on the basis of rpoB, hsp65, and 16S rRNA gene sequences (6) .
In this study, we prospectively compared partial rpoB gene sequencing to our routine algorithm of reverse line blot identification supplemented with partial 16S rRNA gene sequencing, testing 455 clinical NTM isolates received at the Mycobacterium reference laboratory at the National Institute for Public Health and the Environment in the Netherlands (RIVM) during a 15-month period.
MATERIALS AND METHODS
Clinical NTM isolates submitted to the RIVM from January 2010 to March 2011 were subjected to reverse line blot identification (INNOLiPA Mycobacteria v2 [Innogenetics, Ghent, Belgium]; referred to here as LiPA). Isolates identified as Mycobacterium species by this assay but not identifiable to species or complex level with the assay's probes were then identified by partial 16S rRNA gene sequence analysis starting from the position corresponding to Escherichia coli position 28 (479 bp, including the hypervariable regions A and B) (5, 10) . Additionally, isolates were subjected to partial sequencing of the rpoB gene using previously published primers (9) .
Both the 16S rRNA gene and rpoB gene sequences were analyzed using BioNumerics version 6.6 software (Applied Math, Belgium). The sequences were aligned with the GenBank database (NCBI), using the Basic Local Alignment Search Tool (BLAST). For 16S rRNA gene sequencing, identification was based on 100% matches with type strains or reference isolates of validly published species (http://www.bacterio.net /mycobacterium.html) (11) . Isolates without a proper match were labeled "unidentified Mycobacterium species" (UMS) and numbered consecutively. The rpoB gene sequences were interpreted as previously suggested (8, 9) ; i.e., we tolerated 99.3% similarity to type strain sequences for slow growers and 98.3% for rapid growers. Additionally, SGM and RGM isolates with similarities between 94% and 99.3% or 98.3% to type strain sequences were considered identified to complex level only. Isolates showing less than 94% similarity to an accepted species were considered rpoB unidentified Mycobacterium species (rUMS). Additionally, matches with the Mycobacterium terrae complex strain sequences from the study of Tortoli et al. (12) and "M. tilburgii" (13) were also accepted.
If rpoB sequencing results were not supported by GenBank results, the 16S rRNA gene was considered the gold standard. If rpoB sequencing results were supported by LiPA, the LiPA result was considered correct except when a match with another type strain in GenBank was found. In cases of a match with more than one species within the cutoff value, we selected the closest match.
Nucleotide sequence accession numbers. We have deposited the Mycobacterium bohemicum (KJ729110), Mycobacterium heckeshornense (KJ729109), and Mycobacterium conspicuum (HQ141573) sequences we obtained in GenBank.
RESULTS

Screening of 455 NTM isolates using the reverse line blot assay.
Using the LiPA, 417 (92%) of the 455 isolates could be identified to species or complex level based on hybridization with one of the probes identifying a total of 17 NTM species and three NTM complexes (Table 1) . Thirty-eight isolates (8%) could not be identified beyond the genus Mycobacterium, as hybridization with the Mycobacterium genus probe but not with a species-or complex-specific probe was observed in the reverse line assay.
16S rRNA gene versus rpoB gene sequencing. Thirty-eight isolates were classified as Mycobacterium species with the LiPA assay and underwent additional 16S rRNA gene sequencing. These 38 isolates were assigned to 26 different species (27 sequence types in 16S rRNA gene analysis versus 31 sequence types in rpoB gene sequencing), of which five were possibly novel species, and three different isolates could not be identified beyond the M. terrae complex level.
Eleven isolates had matching results in both 16S rRNA gene and rpoB gene sequencing and were identified as (14) . Two isolates showed more than 98.3% similarity with established species by rpoB gene sequencing but showed one base pair mismatch with 16S rRNA gene sequencing: M. phlei (n ϭ 1) and M. novocastrense (n ϭ 1). Three isolates could only be identified by 16S rRNA gene sequences, as no rpoB reference sequence was available for these species: M. bohemicum (n ϭ 1), M. heckeshornense (n ϭ 1), M. conspicuum (n ϭ 1) ( Fig. 1, 2 , and 3).
Six isolates belonged to the M. terrae complex on the basis of both the 16S and rpoB analysis. Three isolates gave a sufficient match with 16S rRNA gene and rpoB gene sequences and were identified as Mycobacterium arupense, M. terrae, and Mycobacterium kumamotonense (12) . The other three isolates could not be assigned to a species but did belong to the M. terrae complex according to both methods, having an rpoB gene sequence similarity of Ͼ94% to validly published M. terrae complex species (10) ( Fig. 1 and 2 ).
Two isolates matched M. fortuitum CIP104534 T 16S rRNA gene sequencing but did not hybridize with the M. fortuitum-M. peregrinum complex (MFO) probe of the LiPA assay. In rpoB gene sequencing, the two exhibited Ͼ99.7% similarity with M. houstonense ATCC 49403 T (AY147173) and a similarity of 98.8% with M. fortuitum CIP104534 T (AY147165) ( Fig. 1 and 3 ). Seven isolates identified as Mycobacterium interjectum on the basis of the 16S rRNA gene sequence were separated into three sequence types on the basis of the rpoB. Three isolates matched M. interjectum DSM44064 (HM022207); the other two sequence types, comprising of four isolates, revealed only 97.9% similarity to the type strain sequence.
For the remaining seven isolates, no good match could be found with either sequencing method. Three isolates were grouped together (rUMS_06) in both methods, but no sufficient match was found with any known Mycobacterium species with either method; the closest match (98.7%) on the basis of 16S rRNA genes was with Mycobacterium agri DSM44515, and in rpoB gene sequencing, the closest match, only 93%, was with Mycobacterium elephantis ( Fig. 1 and 3) .
For four unique isolates (rUMS_02, rUMS_03, rUMS_04, and rUMS_05), no match could be found in both sequencing methods. In 16S rRNA gene sequencing, rUMS_02 (isolate NLA001002310) (Fig. 1) was a 100% match for Mycobacterium sp. strain FI-06081 (DQ986506); the closest species match was Mycobacterium marinum. The other three had 99.0% similarity with Mycobacterium brisbanense, 97.3% similarity with M. triviale, and 99.6% similarity with Mycobacterium frederiksbergense in 16S rRNA gene sequencing (Fig. 1) . In rpoB gene sequencing, the nearest species matches for these three isolates had 90% to 97% similarities according to BLAST (Fig. 2 and 3) . INNO-LiPA assay versus rpoB gene sequencing. With the LiPA, 417 of the 455 isolates could be identified beyond the genus level. The majority of these isolates, 348/417 (83.5%), showed a similar result in rpoB sequencing (Table 1 ).
All isolates of Mycobacterium xenopi (n ϭ 6), M. marinum (n ϭ 16), and M. haemophilum (n ϭ 2) showed more than 99.3% rpoB gene sequence similarity with one another; for M. haemophilum isolates, only a 97.9% similarity with the type strain was observed (Fig. 2) .
Four (80%) of the five isolates identified as Mycobacterium simiae in the LiPA assay exhibited a similarity of more than 99.3% but only 98.3% similarity with the M. simiae type strain, ATCC 25275 (GQ153313). One isolate identified as M. simiae by the LiPA assay was identified as M. tilburgii on the basis of its rpoB gene sequence (Fig. 2) .
The LiPA assay identified three M. kansasii subtypes (MKA1 to -3; Mycobacterium gastri is included in MKA-3). The 43 isolates identified as M. kansasii by the LiPA assay were separated into three discordant groupings by rpoB gene sequencing, with Ͼ99.7% sequence similarity within these three groups ( Fig. 2 and Table 2 ).
According to the LiPA assay, all M. avium (n ϭ 112) and M. malmoense (n ϭ 15) isolates had an rpoB gene sequence similarity of more than 99.3% with the reference strain Mycobacterium avium subsp. hominissuis (IWGMT49; EF521911) or M. malmoense ATCC 29571 T (GQ153314). The other M. avium-intracellulare-scrofulaceum group (MAIS; according to LiPA) isolates showed more variation and could be assigned to seven published species, as depicted in Table 3 and Fig. 2 .
Sixty-two isolates reacted with the M. gordonae probe of the LiPA, of which 49 (79%) showed Ͼ99.3% rpoB gene sequence similarity with M. gordonae ATCC 14770 T (JF346873). The remaining 13 M. gordonae isolates identified by the LiPA showed only 95.8% rpoB gene sequence similarity and were classified as M. gordonae complex (Fig. 2) .
The LiPA separates the M. chelonae-abscesses complex into three different groups (MCH1 to -3). Isolates reacting only with MCH-1 were referred to as M. chelonae, whereas isolates that reacted with both MCH-1 and MCH-2 were referred to as M. abscessus. Reactions with the MCH-3 probe were not seen (Table 1) . Twenty out of 21 (95.2%) isolates that were identified as M. chelonae by the LiPA were identified equally by rpoB gene sequencing (Fig. 3) rium massiliense, but it was within the cutoff value of 98.3% (Fig. 3) .
Twenty-seven isolates were identified as M. fortuitum-M. peregrinum complex (MFO) by the LiPA. Nineteen (70.4%) of these isolates showed a high similarity with either the M. fortuitum (n ϭ 16) or M. peregrinum (n ϭ 3) type strain (Fig. 3) (Fig. 3) .
DISCUSSION
rpoB gene sequencing proved to be more discriminative than the algorithm of LiPA with adjunctive 16S rRNA gene sequencing. Combined, the LiPA assay and adjunctive 16S rRNA gene sequencing identified 390 of the 455 isolates (85.7%) as 30 validly published species and 56 isolates (12.3%) up to complex level, and nine isolates (2%) were assigned to five possibly novel species. By rpoB sequencing, 403 isolates (88.5%) were identified up to species level and assigned to 45 validly published species; 44 isolates (9.7%) were identified up to complex or group level, and eight isolates (1.8%) were assigned to six possibly novel species. In this set of isolates, rpoB gene sequencing identified 15 rRNA gene sequencing is limited among NTM, particularly among RGM (7, 11) . This contributes to the value of the LiPA assay, in addition to its being a more rapid approach than sequencing. Also, for 16S rRNA genes, it is difficult to differentiate between species, because sequences can vary within species (7). Two isolates (NLA001002096 and NLA001100042) were considered UMS on the basis of a 1-bp mismatch in 16S rRNA gene sequences, whereas by rpoB sequencing, the isolates were identified to species level as M. phlei and M. novocastrense.
Additionally, rpoB gene sequencing showed diversity greater than the cutoff for separate species designation within known species, which could in time result in a more precise taxonomy of NTM.
rpoB gene sequencing has been applied in several studies, mostly concentrating on a certain group of NTM, like M. avium complex (MAC) or RGM (8, 9) . Two studies tested a larger variation of NTM species, from both human and veterinary samples (15, 16) . However, the general utility of rpoB sequencing for identification of NTM isolates received at a Mycobacterium reference laboratory remained unclear. Two studies on the usefulness of rpoB sequencing for identification reported a slightly lower percentage of isolates identified to species level: 84% in the study by Simmon et al. of 139 human clinical isolates (16) and 80% in the study by Higgins et al. of 386 animal isolates (15) .
The largest difference between rpoB sequencing and the LiPA/ 16S rRNA gene approach appears to be due to species being grouped together by LiPA/16S rRNA gene but not by rpoB sequencing. Misidentification or oversimplified identification of species by the LiPA has already been reported for M. heidelbergense, M. mantenii, and M. parascrofulaceum; also, the M. fortuitum-peregrinum complex consists of more valid species than M. fortuitum and M. peregrinum (17, 18) . We also noted that the LiPA did not identify two M. houstonense isolates as M. fortuitum-peregrinum complex members, though by 16S rRNA gene and rpoB gene sequencing, this species is part of the M. fortuitum-peregrinum complex.
Both the M. haemophilum and M. simiae isolates in our study group had a high degree of mutual similarity but did not show a high similarity with the type strain rpoB gene sequence present in GenBank. The taxonomy in the M. simiae group has been updated frequently in the past few years and has been found to be more diverse than previously thought (19, 20) . The variation could also be due to a poorly selected type strain, as was also noted for M. terrae by Tortoli et al. (12) .
Our findings indicate that there is more genetic variation within a species than previously suspected, for example, in M. interjectum. Other NTM species have already been grouped into complexes which cluster closely together on the basis of at least 94% similarity, like the MAC, M. chelonae-abscessus complex, M. fortuitum complex, and M. terrae complex (12) . But a higher degree of genetic divergence could be disclosed in groupings like M. kansasii (21) and M. gordonae (22) . Perhaps these two should be regarded as complexes of closely related species, rather than single species. (8, 9) . However, Simmon et al. also noted a lack of interspecies variability for these four species (16) . The general problem is that in mycobacteriology, no cutoffs for separate species based on any genetic targets have been set and agreed upon (7) .
The high degree of similarity between the subspecies and the complicated interpretation of rpoB gene sequencing results have led to a change in status for M. massiliense and M. bolletii from separate species to subspecies, and they are now referred to as M. abscessus subsp. bolletii (24) . However, separation of M. massiliense from M. bolletii and M. abscessus subsp. abscessus has clinical relevance, as M. massiliense is susceptible to macrolides; e.g., clarithromycin-based treatment regimens are more successful in treatment of M. massiliense disease than disease caused by M. bolletii and M. abscessus subsp. abscessus (25) .
It has been noted that rpoB sequencing alone can, in rare instances, misidentify the M. abscessus subspecies, possibly due to horizontal gene transfer (26) . However, horizontal gene transfer would also affect performance of other targets, such as the hsp65 gene (11, 26) . rpoB gene sequencing is still a reasonable first approach; for M. abscessus an interesting second step is erm(41) gene sequencing, which identifies the different subspecies and predicts macrolide susceptibility (25) .
One limitation of rpoB sequencing is the absence of sequence data for type or reference strains of the less commonly encountered NTMs in the GenBank database, as we recorded for M. bohemicum, M. heckeshornense, and M. conspicuum. rpoB gene sequences identified beyond doubt using other targets should be added to the GenBank database. The other limitation, relevant to any genetic target, is the lack of quality assurance in public sequence databases, which may hamper comparisons and requires strict monitoring of results (7, 11) . Public databases inherently suffer from data quality issues, whereas closed, quality-controlled database inherently suffer from data quantity issues, i.e., they are incomplete (7, 11) .
Identifications of NTM based on one genetic target may always result in limited reliability, and sequencing of additional targets will increase the quality of identifications. To resolve issues related to taxonomic status, the definite separate species definition should be provided by whole-genome sequencing of a large collection of NTM isolates. A more exact identification will be most helpful for studying differences in clinical relevance, environmental sources, and epidemiology of human NTM disease (3).
In conclusion, partial rpoB gene sequencing has a higher discriminatory power than a LiPA with adjunctive partial 16S rRNA gene sequencing. Most clinically important species have rpoB gene sequences of type strains available through public databases. On the basis of the data presented here, we consider rpoB sequencing an appropriate first-line identification method for NTM isolated from human samples.
